RhumbLine Advisers
VRTX icon

RhumbLine Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$202M Buy
454,372
+3,341
+0.7% +$1.49M 0.17% 95
2025
Q1
$219M Buy
451,031
+8,670
+2% +$4.2M 0.2% 84
2024
Q4
$178M Sell
442,361
-7,335
-2% -$2.95M 0.16% 99
2024
Q3
$209M Sell
449,696
-8,209
-2% -$3.82M 0.19% 90
2024
Q2
$215M Sell
457,905
-5,322
-1% -$2.49M 0.2% 84
2024
Q1
$194M Buy
463,227
+4,739
+1% +$1.98M 0.19% 96
2023
Q4
$187M Sell
458,488
-5,263
-1% -$2.14M 0.2% 95
2023
Q3
$161M Buy
463,751
+425
+0.1% +$148K 0.19% 94
2023
Q2
$163M Buy
463,326
+12,895
+3% +$4.54M 0.18% 94
2023
Q1
$142M Buy
450,431
+23,694
+6% +$7.47M 0.18% 104
2022
Q4
$123M Buy
426,737
+18,554
+5% +$5.36M 0.17% 113
2022
Q3
$118M Buy
408,183
+12,188
+3% +$3.53M 0.18% 107
2022
Q2
$112M Buy
395,995
+16,679
+4% +$4.7M 0.16% 112
2022
Q1
$99M Sell
379,316
-12,950
-3% -$3.38M 0.13% 142
2021
Q4
$86.1M Buy
392,266
+6,992
+2% +$1.54M 0.11% 163
2021
Q3
$69.9M Sell
385,274
-15,482
-4% -$2.81M 0.09% 182
2021
Q2
$80.8M Sell
400,756
-105,890
-21% -$21.4M 0.11% 164
2021
Q1
$109M Sell
506,646
-15,606
-3% -$3.35M 0.15% 123
2020
Q4
$123M Buy
522,252
+2,345
+0.5% +$554K 0.17% 108
2020
Q3
$141M Sell
519,907
-12,657
-2% -$3.44M 0.22% 83
2020
Q2
$155M Buy
532,564
+28,578
+6% +$8.3M 0.26% 70
2020
Q1
$120M Buy
503,986
+2,341
+0.5% +$557K 0.25% 73
2019
Q4
$110M Sell
501,645
-9,394
-2% -$2.06M 0.18% 106
2019
Q3
$86.6M Buy
511,039
+24,490
+5% +$4.15M 0.16% 125
2019
Q2
$89.2M Buy
486,549
+5,764
+1% +$1.06M 0.17% 114
2019
Q1
$88.4M Buy
480,785
+26,369
+6% +$4.85M 0.17% 113
2018
Q4
$75.3M Buy
454,416
+6,412
+1% +$1.06M 0.16% 118
2018
Q3
$86.3M Sell
448,004
-5,113
-1% -$985K 0.17% 118
2018
Q2
$77M Buy
453,117
+12,823
+3% +$2.18M 0.16% 132
2018
Q1
$71.8M Sell
440,294
-7,641
-2% -$1.25M 0.15% 140
2017
Q4
$67.1M Buy
447,935
+20,478
+5% +$3.07M 0.14% 153
2017
Q3
$65M Buy
427,457
+6,137
+1% +$933K 0.14% 146
2017
Q2
$54.3M Buy
421,320
+2,799
+0.7% +$361K 0.12% 169
2017
Q1
$45.8M Buy
418,521
+2,759
+0.7% +$302K 0.11% 202
2016
Q4
$30.6M Buy
415,762
+17,833
+4% +$1.31M 0.08% 269
2016
Q3
$34.7M Buy
397,929
+20,841
+6% +$1.82M 0.1% 219
2016
Q2
$32.4M Buy
377,088
+16,406
+5% +$1.41M 0.1% 221
2016
Q1
$28.7M Buy
360,682
+13,790
+4% +$1.1M 0.09% 231
2015
Q4
$43.6M Sell
346,892
-1,083
-0.3% -$136K 0.14% 141
2015
Q3
$36.2M Buy
347,975
+4,261
+1% +$444K 0.12% 167
2015
Q2
$42.4M Sell
343,714
-105
-0% -$13K 0.14% 153
2015
Q1
$40.6M Buy
343,819
+3,623
+1% +$427K 0.12% 174
2014
Q4
$40.4M Sell
340,196
-6,337
-2% -$753K 0.12% 178
2014
Q3
$38.9M Sell
346,533
-15,156
-4% -$1.7M 0.12% 183
2014
Q2
$34.2M Buy
361,689
+4,678
+1% +$443K 0.1% 192
2014
Q1
$25.2M Buy
357,011
+6,245
+2% +$442K 0.07% 248
2013
Q4
$26.1M Buy
350,766
+68,474
+24% +$5.09M 0.08% 239
2013
Q3
$21.4M Sell
282,292
-104,222
-27% -$7.9M 0.07% 290
2013
Q2
$30.9M Buy
+386,514
New +$30.9M 0.1% 196